Diagnostic Performance Of Abbreviated MRI For HCC Detection In Patients With Non-Alcoholic Fatty Liver Disease

[1]  C. Dromain,et al.  The combination of non-contrast abbreviated MRI and alpha foetoprotein has high performance for hepatocellular carcinoma screening , 2023, European Radiology.

[2]  Kathryn J Fowler,et al.  Quality Assessment of Ultrasound and Magnetic Resonance Imaging for Hepatocellular Carcinoma Surveillance: A Systematic Review and Meta-Analysis , 2023, Digestive Diseases.

[3]  T. Yokoo,et al.  Multicenter Validation of Abbreviated MRI for Detecting Early-Stage Hepatocellular Carcinoma. , 2023, Radiology.

[4]  F. Underwood,et al.  The prevalence and incidence of NAFLD worldwide: a systematic review and meta-analysis. , 2022, The lancet. Gastroenterology & hepatology.

[5]  N. Syn,et al.  Clinical characteristics, surveillance, treatment allocation, and outcomes of non-alcoholic fatty liver disease-related hepatocellular carcinoma: a systematic review and meta-analysis , 2022, The Lancet. Oncology.

[6]  Robert M. Marks,et al.  Comparative efficacy of an optimal exam between ultrasound versus abbreviated MRI for HCC screening in NAFLD cirrhosis: A prospective study , 2022, Alimentary pharmacology & therapeutics.

[7]  J Zhang,et al.  2019 global NAFLD prevalence - A systematic review and meta-analysis. , 2021, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[8]  Pankaj Gupta,et al.  Reply to "Abbreviated MRI to screen for HCC in patients with cirrhosis. A step forward but a long road ahead". , 2021, Journal of hepatology.

[9]  A. Duseja,et al.  Nonalcoholic Fatty Liver Disease: Indian Perspective , 2021, Clinical liver disease.

[10]  N. Kalra,et al.  Reply to "Risk factors and screening intervals are crucial to evaluating the cost effectiveness of abbreviated MRI in HCC screening". , 2021, Journal of hepatology.

[11]  B. Taouli,et al.  Abbreviated MR Protocols for Chronic Liver Disease and Liver Cancer. , 2021, Magnetic resonance imaging clinics of North America.

[12]  J. Bruix,et al.  Incidence of Hepatocellular Carcinoma in Patients with Non-alcoholic Fatty Liver Disease: A Systematic Review, Meta-analysis, and Meta-regression. , 2021, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[13]  G. Casazza,et al.  Magnetic resonance imaging for the diagnosis of hepatocellular carcinoma in adults with chronic liver disease. , 2021, The Cochrane database of systematic reviews.

[14]  N. Kalra,et al.  Abbreviated MRI for hepatocellular carcinoma screening: A systematic review and meta-analysis. , 2021, Journal of hepatology.

[15]  H. El‐Serag,et al.  Global epidemiology of NAFLD-related HCC: trends, predictions, risk factors and prevention , 2020, Nature Reviews Gastroenterology & Hepatology.

[16]  Michael T. Booker,et al.  Abbreviated MRI for Hepatocellular Carcinoma Screening and Surveillance. , 2020, Radiographics : a review publication of the Radiological Society of North America, Inc.

[17]  M. Strazzabosco,et al.  Surveillance for Hepatocellular Carcinoma in Patients with Non-Alcoholic Fatty Liver Disease: Universal or Selective? , 2020, Cancers.

[18]  A. Sanyal,et al.  Burden of Disease due to Nonalcoholic Fatty Liver Disease. , 2020, Gastroenterology clinics of North America.

[19]  H. El‐Serag,et al.  AGA Clinical Practice Update on Screening and Surveillance for Hepatocellular Carcinoma in Patients with Nonalcoholic Fatty Liver Disease: Expert Review. , 2020, Gastroenterology.

[20]  V. Wong,et al.  Nonalcoholic Steatohepatitis Is the Fastest Growing Cause of Hepatocellular Carcinoma in Liver Transplant Candidates , 2019, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[21]  S. Kedia,et al.  Non-alcoholic fatty liver disease associated with hepatocellular carcinoma: An increasing concern , 2019, The Indian journal of medical research.

[22]  Guibin Wang,et al.  Comparison of values of CT and MRI imaging in the diagnosis of hepatocellular carcinoma and analysis of prognostic factors , 2018, Oncology letters.

[23]  J. Roberts,et al.  Predictors of Ultrasound Failure to Detect Hepatocellular Carcinoma , 2018, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[24]  R. Loomba,et al.  Systematic review with meta‐analysis: risk of hepatocellular carcinoma in non‐alcoholic steatohepatitis without cirrhosis compared to other liver diseases , 2018, Alimentary pharmacology & therapeutics.

[25]  M. Abecassis,et al.  Diagnosis, Staging, and Management of Hepatocellular Carcinoma: 2018 Practice Guidance by the American Association for the Study of Liver Diseases , 2018, Hepatology.

[26]  P. Schirmacher,et al.  EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma. , 2018, Journal of hepatology.

[27]  J. Marrero,et al.  Predictors of adequate ultrasound quality for hepatocellular carcinoma surveillance in patients with cirrhosis , 2017, Alimentary pharmacology & therapeutics.

[28]  L. Henry,et al.  Global epidemiology of nonalcoholic fatty liver disease—Meta‐analytic assessment of prevalence, incidence, and outcomes , 2016, Hepatology.

[29]  H. Tilg,et al.  EASL-EASD-EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease. , 2016, Journal of hepatology.

[30]  Joon Koo Han,et al.  Hepatocellular carcinoma: diagnostic performance of multidetector CT and MR imaging-a systematic review and meta-analysis. , 2015, Radiology.

[31]  A. Sanyal,et al.  NAFLD-related HCC. , 2021, Advances in cancer research.